NO862601D0 - Ekspresjon av protein c. - Google Patents

Ekspresjon av protein c.

Info

Publication number
NO862601D0
NO862601D0 NO862601A NO862601A NO862601D0 NO 862601 D0 NO862601 D0 NO 862601D0 NO 862601 A NO862601 A NO 862601A NO 862601 A NO862601 A NO 862601A NO 862601 D0 NO862601 D0 NO 862601D0
Authority
NO
Norway
Prior art keywords
protein
nucleotide sequence
disclosed
mammalian host
biological activity
Prior art date
Application number
NO862601A
Other languages
English (en)
Other versions
NO305660B1 (no
NO862601L (no
Inventor
Mark J Murray
Kathleen L Berkner
Donald C Foster
Earl W Davie
Original Assignee
Zymogenetics Inc
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27115147&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO862601(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/766,109 external-priority patent/US4968626A/en
Application filed by Zymogenetics Inc, Univ Washington filed Critical Zymogenetics Inc
Publication of NO862601D0 publication Critical patent/NO862601D0/no
Publication of NO862601L publication Critical patent/NO862601L/no
Publication of NO305660B1 publication Critical patent/NO305660B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
NO862601A 1985-06-27 1986-06-27 DNA-sekvens som koder for et human-aktivert protein C, rekombinant ekspresjonsvektor som omfatter DNA-sekvensen, pattedyrceller transfektert med ekspresjonsvektoren og fremgangsmÕte for fremstilling av human-aktivert protein C NO305660B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74960085A 1985-06-27 1985-06-27
US06/766,109 US4968626A (en) 1985-08-15 1985-08-15 DNA sequence coding for protein C

Publications (3)

Publication Number Publication Date
NO862601D0 true NO862601D0 (no) 1986-06-27
NO862601L NO862601L (no) 1986-12-29
NO305660B1 NO305660B1 (no) 1999-07-05

Family

ID=27115147

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862601A NO305660B1 (no) 1985-06-27 1986-06-27 DNA-sekvens som koder for et human-aktivert protein C, rekombinant ekspresjonsvektor som omfatter DNA-sekvensen, pattedyrceller transfektert med ekspresjonsvektoren og fremgangsmÕte for fremstilling av human-aktivert protein C

Country Status (7)

Country Link
EP (1) EP0215548B2 (no)
JP (2) JP2614848B2 (no)
AT (1) ATE93272T1 (no)
CA (1) CA1341228C (no)
DE (1) DE3688900T3 (no)
DK (1) DK175574B1 (no)
NO (1) NO305660B1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959318A (en) * 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C
US5550036A (en) 1986-04-09 1996-08-27 Eli Lilly And Company Method for co-amplification of human protein C genes in human cells
USH1148H (en) 1987-04-17 1993-03-02 Method of separating activated human protein C
JP2799316B2 (ja) * 1987-06-12 1998-09-17 ヘキスト・マリオン・ルセル株式会社 雑種ヒトプロテインｃおよびその遺伝子工学的製法
US5084274A (en) * 1987-11-17 1992-01-28 Scripps Clinic And Research Foundation Inhibition of arterial thrombotic occlusion or thromboembolism
US4992373A (en) * 1987-12-04 1991-02-12 Eli Lilly And Company Vectors and compounds for direct expression of activated human protein C
US5196322A (en) * 1987-12-28 1993-03-23 Eli Lilly And Company Vectors and compounds for expression of zymogen forms of human protein C
JP2728240B2 (ja) * 1988-07-26 1998-03-18 ヘキスト薬品工業株式会社 ヒトプロテインｃ変異体及びその製造方法
CA1332049C (en) * 1988-10-07 1994-09-20 Eli Lilly And Company Eukaryotic expression
JP3045307B2 (ja) * 1989-08-11 2000-05-29 ザイモジェネティクス，インコーポレイティド 活性化プロテインｃを生成するための細胞培養法
JP2774156B2 (ja) * 1989-09-05 1998-07-09 帝人株式会社 ヒトプロテインｃおよび／または活性化ヒトプロテインｃ様活性を有する蛋白
JP2774163B2 (ja) * 1989-11-14 1998-07-09 帝人株式会社 ヒトプロテインｃ様活性を有する蛋白
US5358932A (en) * 1989-12-29 1994-10-25 Zymogenetics, Inc. Hybrid protein C
DE69032029T2 (de) * 1989-12-29 1998-08-20 Zymogenetics Inc Hybrides protein c
US5270178A (en) * 1990-02-23 1993-12-14 Eli Lilly And Company Vectors and compounds for expression of zymogen forms of human protein C
IL97311A0 (en) * 1990-02-23 1992-05-25 Lilly Co Eli Vectors and compounds for expression of glycosylation mutants of human protein c
AT402263B (de) * 1991-06-20 1997-03-25 Immuno Ag Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
US5443968A (en) * 1992-05-01 1995-08-22 Teijin Limited Fed batch culture method for protein secreting cells
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
US5561053A (en) * 1994-08-05 1996-10-01 Genentech, Inc. Method for selecting high-expressing host cells
CA2391651A1 (en) * 1999-11-19 2001-05-25 Eli Lilly And Company Protein c derivatives
BRPI0611376A2 (pt) * 2005-05-24 2010-08-31 Avestha Gengraine Tech Pvt Ltd processo para a producão de proteìna c ativada humana para o tratamento de sepsia
US10758179B2 (en) 2012-10-23 2020-09-01 Koninklijke Philips N.V. Stress-measuring system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8327860D0 (en) * 1983-10-18 1983-11-16 Fujisawa Pharmaceutical Co Monoclonal antiprotein c antibody
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C

Also Published As

Publication number Publication date
DK308586D0 (da) 1986-06-27
DK175574B1 (da) 2004-12-13
JPS62111690A (ja) 1987-05-22
CA1341228C (en) 2001-05-15
DE3688900T3 (de) 1998-06-10
JPH09107976A (ja) 1997-04-28
JP2614848B2 (ja) 1997-05-28
EP0215548B1 (en) 1993-08-18
EP0215548B2 (en) 1998-01-07
ATE93272T1 (de) 1993-09-15
JP2688407B2 (ja) 1997-12-10
DK308586A (da) 1986-12-28
NO305660B1 (no) 1999-07-05
NO862601L (no) 1986-12-29
DE3688900D1 (de) 1993-09-23
DE3688900T2 (de) 1993-12-09
EP0215548A1 (en) 1987-03-25

Similar Documents

Publication Publication Date Title
NO874495L (no) Ekspresjon av protein c.
NO862601L (no) Ekspresjon av protein c.
ATE391175T1 (de) Multidrug resistenz gen
FI963246A (fi) Geeniterapiassa käytettävä isäntävektorijärjestelmä
ATE88501T1 (de) Rekombinante dns-expressionsvektoren.
NO870323L (no) Fremgangsmaate for fremstilling av et rekombinant proteinkompleks med humanfaktor v111:c-aktivitet.
DE69828193D1 (de) Hyaluronan synthase gen und seine verwendung
EP0111814A3 (en) The cloning and expression of nucleotide sequences encoding bovine growth hormone
EP0835661A3 (en) Human interferon-Beta2A for use as a medicament
ES2078243T3 (es) Mejoras en o relativas a la expresion eucariotica.
EP0336383A3 (en) Novel recombinant human lymphotoxin
AU6560886A (en) DNA sequence containing the DNA sequence coding for human tissue plasminogen activator originating from human normal cells, recombinant DNA incorporating the DNA sequence, host cells transformed with the recombinant DNA, and process for producing human tissue plasminogen activator by use of the host cells
EP0282512A4 (en) STABILIZATION OF MESSENGER RNA IN ANIMAL CELLS.
ATE111527T1 (de) Herstellung und verwendung einer dna zur erhöhung der ausbeute bei der expression von rekombinanten genen.
WO1991009951A3 (en) Recombinant protein c with truncated light chain

Legal Events

Date Code Title Description
MK1K Patent expired